Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-08 5:03 pm Purchase | 2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Gautam | 30,812,108 10.000% | 17,497,336 (+131.41%) | Filing History |
| 2023-11-08 4:59 pm Unchanged | 2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Chintu | 25,318,839 8.300% | 0 (Unchanged) | Filing History |
| 2023-11-08 4:55 pm Unchanged | 2023-11-07 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Tushar Bhikhubhai | 53,578,209 17.500% | 0 (Unchanged) | Filing History |
| 2023-10-17 7:32 pm Unchanged | 2023-10-16 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Dipan | 26,905,073 14.900% | 0 (Unchanged) | Filing History |
| 2023-10-17 7:31 pm Purchase | 2023-10-16 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Chirag K. | 21,835,007 14.160% | 534,503 (+2.51%) | Filing History |
| 2023-10-17 7:30 pm Purchase | 2023-10-16 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Chintu | 25,318,839 16.410% | 534,503 (+2.16%) | Filing History |
| 2023-10-17 7:27 pm Unchanged | 2023-10-16 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Tushar Bhikhubhai | 53,578,209 25.800% | 0 (Unchanged) | Filing History |
| 2023-10-17 7:25 pm Sale | 2023-10-16 | 13D | Amneal Pharmaceuticals, Inc. AMRX | Patel Gautam | 13,314,772 8.630% | -17,101,081 (-56.22%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Amneal Pharmaceuticals, Inc. AMRX | The Vanguard Group | 13,048,068 8.610% | 1,473,173 (+12.73%) | Filing History |
| 2022-12-14 5:05 pm Sale | 2022-12-12 | 13D | Amneal Pharmaceuticals, Inc. AMRX | TPG GP A, LLC | 12,328,767 8.100% | -3,884,600 (-23.96%) | Filing History |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | The Vanguard Group | 11,574,895 7.750% | 592,064 (+5.39%) | Filing History |
| 2022-01-18 5:32 pm Purchase | 2022-01-12 | 13D | Amneal Pharmaceuticals, Inc. AMRX | TPG GP A, LLC | 16,213,367 10.900% | 16,213,367 (New Position) | Filing History |
| 2021-04-12 08:02 am Sale | 2021-03-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | Wellington Management Group LLP | 54,742 0.040% | -13,851,674 (-99.61%) | Filing History |
| 2021-02-10 3:04 pm Sale | 2021-01-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | BlackRock Inc. BLK | 7,342,865 4.970% | -63,930 (-0.86%) | Filing History |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | The Vanguard Group | 10,982,831 7.440% | 797,756 (+7.83%) | Filing History |
| 2021-02-03 1:33 pm Sale | 2020-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | Wellington Management Group LLP | 13,906,416 9.420% | -1,621,036 (-10.44%) | Filing History |
| 2021-01-28 5:56 pm Sale | 2020-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | BlackRock Inc. BLK | 7,406,795 5.000% | -1,987,829 (-21.16%) | Filing History |